DexCom’s shares shot up as much as 8% in the trading session following the announcement. The stock has been up 2.6% since the news release. Currently, the DexCom G4 PLATINUM (Pediatric) is the only ...

The Julphar revolutionary real-time continuous glucose monitoring device (CGM), DEXCOM G4 PLATINUM is now available in UAE, KSA, Kuwait and Oman and will soon be available in Qatar, Bahrain and ...

FDA classifies this as a Class I recall, which means using the device could result in adverse health effects or death. Dexcom Inc., has recalled its G4 Platinum and G5 Mobile continuous glucose ...

Dexcom has received approval from the FDA for a new version of its smartphone connected Dexcom Share platform that will eliminate the docking cradle and allow a patient's continuous glucose monitor ...

The US Food and Drug Administration (FDA) has approved a new insulin pump/continuous glucose monitor (CGM) product, Tandem's t:slim Insulin Pump and Dexcom G4 PLATINUM CGM System, according to a ...

The Dexcom G4 receiver, which will have an "identical" form factor to the forthcoming Bluetooth version. In a call to investors days after its app won FDA approval, Dexcom CEO Kevin Sayer shared some ...

Jonas, Who Has Type 1 Diabetes, Sings Praises for the Life-Changing Impact of Continuous Glucose Monitoring San Diego, CA, June 11, 2015 – Dexcom, Inc., (NASDAQ:DXCM), a leader in continuous glucose ...

Continuous glucose monitor company Dexcom has hit a stumbling block. Some of its devices, including the G5 receiver for a system that just launched last fall, are not providing the audio alarms and ...

DexCom, Inc.DXCM recently announced the signing of a development agreement with Eli Lilly and Company LLY. Per the agreement, DexCom's flagship continuous glucose monitoring system (CGM) will be added ...

Dexcom, the company behind one of the leading continuous glucose monitor solutions for diabetes patients, has announced today that their “Follow” mobile app—which has long been available on iOS—is now ...

DexCom, Inc. DXCM is well poised for growth on the back of solid international presence and robust product portfolio. The stock has gained 212.8%, compared with the industry’s growth of 14.3% in a ...